Multiple Sclerosis
Conference Coverage
Balancing privacy, protection in at-risk MS patients
SEATTLE – Keep HIPAA, state laws, and professional guidelines in mind as you consider confidentiality’s limits, an attorney and neuroethics fellow...
Conference Coverage
Pediatric MS often goes untreated in the year after diagnosis
SEATTLE – About 65% of patients with pediatric multiple sclerosis do not receive disease-modifying therapy (DMT) within 1 year of diagnosis....
Video
Steady advances made since recognition of neuromyelitis optica 20 years ago
SEATTLE – Dr. Brian Weinshenker discusses the progress made in understanding and managing neuromyelitis optica.
Conference Coverage
Restless legs syndrome in MS linked to cognitive impairment
SEATTLE – Sleep dysfunction could be the key link, study suggests.
Video
Developing new measurements for better MS outcomes
SEATTLE – Researchers are working on developing more sensitive ways of measuring MS disease status.
Conference Coverage
Mindfulness meditation may boost cognition in MS
SEATTLE – Brief mindfulness meditation may improve cognitive processing speed in patients with MS more than adaptive computerized cognitive...
Conference Coverage
Switching from interferon beta-1a to alemtuzumab improves MS outcomes
SEATTLE – The switch is associated with a high rate of freedom from relapse and a reduced rate of brain volume loss...
Conference Coverage
Even if successful, IVF may boost relapses in MS
SEATTLE – Relapses don’t just rise in women who fail fertility treatment, study suggests.
Conference Coverage
MS patients pay big price for breaks from DMT
SEATTLE – They suffer more relapses, hospitalizations, and ER visits, a study finds, and nondrug costs are higher.
Conference Coverage
Evidence lacking in treatments for pain in MS
SEATTLE – But research does provide some insights into medication strategies for pain, specialists say.